Robertson S M, Ling V, Stanners C P
Mol Cell Biol. 1984 Mar;4(3):500-6. doi: 10.1128/mcb.4.3.500-506.1984.
A genetic system comprised of mammalian cell mutants which demonstrate concomitant resistance to a number of unrelated drugs has been described previously. The resistance is due to reduced cell membrane permeability and is correlated with the presence of large amounts of a plasma membrane glycoprotein termed P-glycoprotein. This system could represent a model for multiple drug resistance which develops in cancer patients treated with chemotherapeutic drugs. We demonstrate here that the multiple drug resistance phenotype can be transferred to mouse cells with DNA from a drug-resistant mutant and then amplified quantitatively by culture in media containing increasing concentrations of drug. The amount of P-glycoprotein was correlated directly with the degree of drug resistance in the transformants and amplified transformants. In addition, the drug resistance and expression of P-glycoprotein of the transformants were unstable and associated quantitatively with the number of double minute chromosomes. We suggest that the gene for multiple drug resistance and P-glycoprotein is contained in these extrachromosomal particles and is amplified by increases in double minute chromosome number. The potential use of this system for manipulation of mammalian genes in general is discussed.
先前已描述了一种由哺乳动物细胞突变体组成的遗传系统,这些突变体对多种不相关药物具有伴随抗性。这种抗性是由于细胞膜通透性降低,并且与大量称为P-糖蛋白的质膜糖蛋白的存在相关。该系统可能代表了癌症患者接受化疗药物治疗时产生的多药耐药性模型。我们在此证明,多药耐药表型可以通过耐药突变体的DNA转移到小鼠细胞中,然后通过在含有浓度不断增加的药物的培养基中培养进行定量扩增。P-糖蛋白的量与转化体和扩增转化体中的耐药程度直接相关。此外,转化体的耐药性和P-糖蛋白的表达不稳定,并且与双微体染色体的数量在数量上相关。我们认为,多药耐药和P-糖蛋白的基因包含在这些染色体外颗粒中,并通过双微体染色体数量的增加而扩增。本文还讨论了该系统在一般情况下用于操纵哺乳动物基因的潜在用途。